BRPI0410233A - amidas de ácido isoquinolino-3-carboxìlico e usos farmacêuticos das mesmas - Google Patents
amidas de ácido isoquinolino-3-carboxìlico e usos farmacêuticos das mesmasInfo
- Publication number
- BRPI0410233A BRPI0410233A BRPI0410233-9A BRPI0410233A BRPI0410233A BR PI0410233 A BRPI0410233 A BR PI0410233A BR PI0410233 A BRPI0410233 A BR PI0410233A BR PI0410233 A BRPI0410233 A BR PI0410233A
- Authority
- BR
- Brazil
- Prior art keywords
- carboxylic acid
- acid amides
- isoquinoline
- pharmaceutical uses
- pharmaceuticals
- Prior art date
Links
- KKSZSACCVDIWIE-UHFFFAOYSA-N isoquinoline-3-carboxamide Chemical class C1=CC=C2C=NC(C(=O)N)=CC2=C1 KKSZSACCVDIWIE-UHFFFAOYSA-N 0.000 title abstract 2
- 230000001270 agonistic effect Effects 0.000 abstract 1
- 102000047725 alpha7 Nicotinic Acetylcholine Receptor Human genes 0.000 abstract 1
- 108700006085 alpha7 Nicotinic Acetylcholine Receptor Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"AMIDAS DE áCIDO ISOQUINOLINO-3-CARBOXìLICO E USOS FARMACêUTICOS DAS MESMAS". A presente invenção refere-se a novas amidas do ácido isoquinolino-3-carboxílico com atividade agonística ao receptor de acetilcolina <244>7 nicotínico, sua preparação, seu uso como produtos farmacêuticos e composições farmacêuticas contendo as mesmas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0310867.7A GB0310867D0 (en) | 2003-05-12 | 2003-05-12 | Organic compounds |
| PCT/EP2004/005042 WO2004099206A1 (en) | 2003-05-12 | 2004-05-11 | Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0410233A true BRPI0410233A (pt) | 2006-05-09 |
Family
ID=9957894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0410233-9A BRPI0410233A (pt) | 2003-05-12 | 2004-05-11 | amidas de ácido isoquinolino-3-carboxìlico e usos farmacêuticos das mesmas |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7683075B2 (pt) |
| EP (1) | EP1633752B1 (pt) |
| JP (1) | JP2006525976A (pt) |
| CN (1) | CN100341874C (pt) |
| AT (1) | ATE483710T1 (pt) |
| AU (1) | AU2004235971C1 (pt) |
| BR (1) | BRPI0410233A (pt) |
| CA (1) | CA2524625A1 (pt) |
| DE (1) | DE602004029462D1 (pt) |
| GB (1) | GB0310867D0 (pt) |
| MX (1) | MXPA05012154A (pt) |
| WO (1) | WO2004099206A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR108325A1 (es) | 2016-04-27 | 2018-08-08 | Samumed Llc | Isoquinolin-3-il carboxamidas y preparación y uso de las mismas |
| AR108326A1 (es) | 2016-04-27 | 2018-08-08 | Samumed Llc | Isoquinolin-3-il carboxamidas y preparación y uso de las mismas |
| TWI865563B (zh) | 2019-07-30 | 2024-12-11 | 德商拜耳動物保健有限公司 | 新穎異喹啉衍生物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0311724A1 (en) | 1987-10-16 | 1989-04-19 | Synthelabo | Anxiolytic-R-N-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides |
| FR2625678B1 (fr) | 1988-01-13 | 1991-06-07 | Delalande Sa | Agents anorexigenes a base de n-(quinuclidin-3-yl)-benzamides ou thiobenzamides |
| ATE85217T1 (de) | 1988-08-04 | 1993-02-15 | Synthelabo | Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.>oct-3-yl)benzamide und thiobenzamide. |
| EP0353371A1 (en) | 1988-08-04 | 1990-02-07 | Synthelabo | Memory enhancing-R-N-(1-azabicyclo[2.2.2] oct-3-yl) benzamides and thiobenzamides |
| GB9009542D0 (en) | 1990-04-27 | 1990-06-20 | Beecham Group Plc | Novel compounds |
| SE9600683D0 (sv) | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
| SE0000540D0 (sv) * | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
| PE20021019A1 (es) | 2001-04-19 | 2002-11-13 | Upjohn Co | Grupos azabiciclicos sustituidos |
| AR036041A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
| CA2460075A1 (en) * | 2001-09-12 | 2003-03-20 | Donn Gregory Wishka | Substituted 7-aza[2.2.1] bicycloheptanes for the treatment of diseases |
| JP2005511574A (ja) * | 2001-10-26 | 2005-04-28 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | Nachrアゴニストとしてのn−アザビシクロ−置換ヘテロ二環式カルボキサミド |
| MXPA04007083A (es) * | 2002-02-20 | 2004-10-29 | Upjohn Co | Compuestos azabiciclicos para el tratamiento de enfermedades. |
| AU2003279492A1 (en) * | 2002-12-11 | 2004-06-30 | Pharmacia & Upjohn Company Llc | Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds |
| CA2509142A1 (en) * | 2002-12-11 | 2004-06-24 | Pharmacia & Upjohn Company Llc | Combination for the treatment of adhd |
| MXPA05007689A (es) * | 2003-01-22 | 2005-09-30 | Pharmacia & Upjohn Co Llc | Tratamiento de enfermedades con agonistas completos del receptor alfa-7 de nach. |
-
2003
- 2003-05-12 GB GBGB0310867.7A patent/GB0310867D0/en not_active Ceased
-
2004
- 2004-05-11 MX MXPA05012154A patent/MXPA05012154A/es active IP Right Grant
- 2004-05-11 CN CNB2004800124422A patent/CN100341874C/zh not_active Expired - Fee Related
- 2004-05-11 WO PCT/EP2004/005042 patent/WO2004099206A1/en not_active Ceased
- 2004-05-11 EP EP04732091A patent/EP1633752B1/en not_active Expired - Lifetime
- 2004-05-11 US US10/556,356 patent/US7683075B2/en not_active Expired - Fee Related
- 2004-05-11 CA CA002524625A patent/CA2524625A1/en not_active Abandoned
- 2004-05-11 AT AT04732091T patent/ATE483710T1/de not_active IP Right Cessation
- 2004-05-11 BR BRPI0410233-9A patent/BRPI0410233A/pt not_active IP Right Cessation
- 2004-05-11 DE DE602004029462T patent/DE602004029462D1/de not_active Expired - Lifetime
- 2004-05-11 JP JP2006505416A patent/JP2006525976A/ja active Pending
- 2004-05-11 AU AU2004235971A patent/AU2004235971C1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20070142428A1 (en) | 2007-06-21 |
| DE602004029462D1 (de) | 2010-11-18 |
| CN1784404A (zh) | 2006-06-07 |
| JP2006525976A (ja) | 2006-11-16 |
| CA2524625A1 (en) | 2004-11-18 |
| EP1633752A1 (en) | 2006-03-15 |
| MXPA05012154A (es) | 2006-02-08 |
| AU2004235971C1 (en) | 2008-12-04 |
| CN100341874C (zh) | 2007-10-10 |
| EP1633752B1 (en) | 2010-10-06 |
| ATE483710T1 (de) | 2010-10-15 |
| US7683075B2 (en) | 2010-03-23 |
| AU2004235971B2 (en) | 2008-04-03 |
| AU2004235971A1 (en) | 2004-11-18 |
| GB0310867D0 (en) | 2003-06-18 |
| WO2004099206A1 (en) | 2004-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051102L (no) | Sulfonylamino-eddiksyre-derivater | |
| TW200505875A (en) | Novel compounds | |
| NO20062677L (no) | Benzyleteraminforbindelser anvendbare som CCR-5-antagonister | |
| NO20054185D0 (no) | Methods of radiofluorination of biologically active vectors | |
| BRPI0413728A (pt) | muteìnas de lipocalina da lágrima | |
| BR0315547A (pt) | Derivados de quinolina como antagonistas de crth2 | |
| NO20061003L (no) | Pyridazinlpiperainer og anvendelse derav som histamin-H3-reseptorligander | |
| ATE485304T1 (de) | Muteine von tearlipocalin und verfahren zu deren gewinnung | |
| MY140840A (en) | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals | |
| DE60028970D1 (de) | An her2 bindende peptidverbindungen | |
| TW200508197A (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| TW200611695A (en) | Pyrrolopyridine derivatives | |
| EP1423137A4 (en) | Lipopeptide stereoisomers, methods for preparing same, and useful intermediates | |
| BRPI0415015A (pt) | certas lactamas espirocìclicas substituìdas e uso destas como produtos farmacêuticos | |
| DK1511489T3 (da) | Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A | |
| WO2004106322A3 (en) | Polymorphs of aripiprazole | |
| TW200716204A (en) | Pharmaceutical composition | |
| GB0320320D0 (en) | Novel compounds | |
| TW200716529A (en) | New compounds II | |
| TW200745024A (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
| ATE402958T1 (de) | Antagonisten des ige-rezeptors | |
| SE0300457D0 (sv) | Novel compounds | |
| BR0213574A (pt) | Compostos básicos lineares apresentando atividade antagonista do nk-2 e formulações contendo os mesmos | |
| ATE483710T1 (de) | Isochinolin-3-carbonsäureamide und ihre pharmazeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |